Lynda Davies thought she’d tried everything to relieve the excruciating pain in her shoulder caused by bursitis. Until she ...

Iran nuclear talks: Iran has roughly doubled its stockpile of near-bomb-grade uranium over the past three months as it ...

The research: Numerous studies over decades have linked consumption of ultraprocessed foods to diseases or health issues ...

SHANGHAI, China I May 30, 2025 I Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim ...

The OxStu discusses the causes and implications of antimicrobial resistance, and the social and scientific methods to combat ...

Japan’s foray into regenerative medicine takes on added importance for a nation wrestling with age, stagnation, and its place ...

NurExone expects to initiate a Phase 1/2a clinical trial in 2026 (“ 2026 SCI Trial ”) marking a major milestone in the advancement of regenerative therapies for central nervous system injuries.